Thor Medical Asa (TRMED.OL) traded down -0.95 % during a 24 hours period ending at 12:52 AM Central Europe on Wednesday 28th. One Thor Medical Asa stock can currently be bought for about NOK 4.24 on popular exchanges. Current supply of Thor Medical Asa stocks is 425.5 mn. Thor Medical Asa has a current market capitalization of NOK 1.8 bn and approximately NOK 10.9 mn worth of Thor Medical Asa was traded on exchanges in the last 24 hours. Since last month end, Thor Medical Asa has traded -7.35 % down. Simple moving average of last 200 days is at NOK 4.74. The highest price of past 52 weeks was recorded at NOK 7.12 on 08/26/2026. 52 weeks low was at NOK 3.31 on 10/30/2025.

Here is how related stocks have performed in the past 24 hours:

  • Byggma Asa (BMA.OL) traded down -3.23 % and now trades at NOK 23.4. Current market capitalisation for Byggma Asa is NOK 1.7 bn. Current price/earnings ratio for Byggma Asa is 26.39.

  • Prosafe (PRS.OL) traded up 1.27 % and now trades at NOK 4.8. Current market capitalisation for Prosafe is NOK 1.7 bn. Prosafe has a current price to earnings ratio of 0.98.

  • Nrc Asa (NRC.OL) traded up 1.05 % and now trades at NOK 9.74. Nrc Asa has a market capitalisation of NOK 1.7 bn. Nrc Asa has a current price to earnings ratio of 101.47.

  • Archer (ARCH.OL) traded up 5.09 % and now trades at NOK 19. Current market capitalisation for Archer is NOK 1.9 bn.

  • Bevest Asa (KMCP.OL) traded flat 0 % and now trades at NOK 20.7. Bevest Asa has a market capitalisation of NOK 2.1 bn.

About Thor Medical Asa

Thor Medical ASA is a medical technology company based in Sandvika, Sweden. The company specializes in developing innovative solutions for neurosurgery and orthopedic surgery, with a particular focus on neuroendovascular and neurotrauma care. Thor Medical ASA’s product range includes a variety of imaging and navigation systems, as well as neurosurgery tools and software. The company’s main goal is to revolutionize the field of neurosurgery by providing more precise and efficient solutions for neuroendovascular and neurotrauma patients.